Prognostic properties of the baseline prostate-specific antigen value-insights from the European randomized study of screening for prostate cancer

被引：0
|
作者：
Scherer, Thomas Paul [1 ]
Poyet, Cedric [1 ,2 ]
机构：
[1] Univ Zurich, Univ Hosp Zurich, Dept Urol, Zurich, Switzerland
[2] Univ Hosp Zurich, Dept Urol, Ramistr 100, CH-8091 Zurich, Switzerland
来源：
TRANSLATIONAL ANDROLOGY AND UROLOGY | 2024年 / 13卷 / 03期
关键词：
Screening; prostate-specific antigen (PSA); prostate cancer (PCa); RISK;
D O I：
10.21037/tau-23-606
中图分类号：
R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
摘要：
引用
收藏
页码：473 / 475
页数：3
相关论文
共 50 条
  • [21] Randomized controlled screening trials for prostate cancer using prostate-specific antigen: a tale of contrasts
    Rove, Kyle O.
    Crawford, E. David
    WORLD JOURNAL OF UROLOGY, 2012, 30 (02) : 137 - 142
  • [22] Randomized controlled screening trials for prostate cancer using prostate-specific antigen: a tale of contrasts
    Kyle O. Rove
    E. David Crawford
    World Journal of Urology, 2012, 30 : 137 - 142
  • [23] Management of prostate-specific antigen relapse in prostate cancer: A European consensus
    Boccon-Gibod, L
    Djavan, B
    Hammerer, P
    Hoeltl, W
    Kattan, MW
    Prayer-Galetti, T
    Teillac, P
    Tunn, UW
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2004, 58 (04) : 382 - 390
  • [24] Screening Prostate-specific Antigen Concentration and Prostate Cancer Mortality: The Korean Heart Study
    Mok, Yejin
    Kimm, Heejin
    Shin, Sang Yop
    Jee, Sun Ha
    Platz, Elizabeth A.
    UROLOGY, 2015, 85 (05) : 1111 - 1116
  • [25] Overdetection, overtreatment and costs in prostate-specific antigen screening for prostate cancer
    E A M Heijnsdijk
    A der Kinderen
    E M Wever
    G Draisma
    M J Roobol
    H J de Koning
    British Journal of Cancer, 2009, 101 : 1833 - 1838
  • [26] Prostate-Specific Antigen (PSA) Screening for Prostate Cancer Revisiting the Evidence
    Carter, H. Ballentine
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2018, 319 (18): : 1866 - 1868
  • [27] Overdetection, overtreatment and costs in prostate-specific antigen screening for prostate cancer
    Heijnsdijk, E. A. M.
    der Kinderen, A.
    Wever, E. M.
    Draisma, G.
    Roobol, M. J.
    de Koning, H. J.
    BRITISH JOURNAL OF CANCER, 2009, 101 (11) : 1833 - 1838
  • [28] African Americans' Perceptions of Prostate-Specific Antigen Prostate Cancer Screening
    Hunter, Jaimie C.
    Vines, Anissa I.
    Carlisle, Veronica
    HEALTH EDUCATION & BEHAVIOR, 2015, 42 (04) : 539 - 544
  • [29] Prostate Cancer Mortality Reduction by Prostate-Specific Antigen-Based Screening Adjusted for Nonattendance and Contamination in the European Randomised Study of Screening for Prostate Cancer (ERSPC)
    Roobol, Monique J.
    Kerkhof, Melissa
    Schroeder, Fritz H.
    Cuzick, Jack
    Sasieni, Peter
    Hakama, Matti
    Stenman, Ulf Hakan
    Ciatto, Stefano
    Nelen, Vera
    Kwiatkowski, Maciej
    Lujan, Marcos
    Lilja, Hans
    Zappa, Marco
    Denis, Louis
    Recker, Franz
    Berenguer, Antonio
    Ruutu, Mirja
    Kujala, Paula
    Bangma, Chris H.
    Aus, Gunnar
    Tammela, Teuvo L. J.
    Villers, Arnauld
    Rebillard, Xavier
    Moss, Sue M.
    de Koning, Harry J.
    Hugosson, Jonas
    Auvinen, Anssi
    EUROPEAN UROLOGY, 2009, 56 (04) : 584 - 591
  • [30] Baseline Serum Prostate-specific Antigen Value Predicts the Risk of Subsequent Prostate Cancer Death-Results from the Norwegian Prostate Cancer Consortium
    Bjerner, Johan
    Bratt, Ola
    Aas, Kirsti
    Albertsen, Peter C.
    Fossa, Sophie D.
    Kvale, Rune
    Lilja, Hans
    Muller, Christoph
    Muller, Stig
    Stensvold, Andreas
    Thomas, Owen
    Roe, Oluf D.
    Vickers, Andrew
    Walz, Jochen
    Carlsson, Sigrid, V
    Oldenburg, Jan
    EUROPEAN UROLOGY, 2024, 86 (01) : 20 - 26
12345